跳至主要内容
临床试验/NCT00149279
NCT00149279已完成3 期

Randomized Controlled Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer (JCOG9501)

Japan Clinical Oncology Group2 个研究点 分布在 1 个国家目标入组 520 人开始时间: 1995年7月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
520
试验地点
2
主要终点
overall survival

研究概览

简要总结

To evaluate the survival benefit of para-aortic lymphadenectomy in potentially curative gastrectomy

详细描述

Radical gastrectomy with regional lymphadenectomy is the only curative treatment option for gastric cancer. The extent of lymphadenectomy, however, is controversial. The two European randomized trials only reported an increase in operative morbidity and mortality, but failed to show survival benefit, in the D2 lymphadenectomy group. We conducted a randomized controlled trial to compare the Japanese standard D2 and D2 + para-aortic nodal dissection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Preoperatively,
  • histologically proven adenocarcinoma
  • 75 years old or younger
  • forced expiratory volume in one second ≥ 50 %
  • arterial oxygen pressure in room air ≥ 70 mmHg
  • creatinine clearance ≥ 50 ml/min
  • written consent. Intraoperatively
  • Macroscopic T staging is T2-subserosa, T3, or T4
  • potentially curative operation is possible
  • no gross metastasis in para-aortic nodes (frozen section diagnosis not allowed)
  • peritoneal lavage cytology is negative for cancer cells

排除标准

  • Carcinoma in the remnant stomach
  • Borrmann type 4 (linitis plastica)
  • synchronous or metachronous malignancy in other organs except for cervical carcinoma in situ and colorectal focal cancer in adenoma
  • past history of myocardial infarction or positive results of exercise ECG
  • liver cirrhosis, or chronic liver disease with indocyanine green test ≥10%

结局指标

主要结局

overall survival

次要结局

  • relapse-free survival
  • operative morbidity and mortality
  • length of postoperative hospital stay
  • quality of life

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验